Immune signaling
Thymosin Alpha 1
A thymic peptide with a substantial immune-signaling literature.
Evidence score4/5
Substantial clinical evidence
- Evidence
- Mixed translational
- Status
- Published
Topic authority hub
Immune Function
Thymic peptides, inflammation-linked models, cytokine context, and immune-adjacent recovery research.
Research frame
Immune-function research ranges from thymic peptide signaling to inflammatory gene expression and disease-specific clinical programs.
This hub separates TA1, thymulin, GHK-Cu, and Selank contexts instead of treating every immune signal as the same intervention class.
Featured compounds
Immune signaling
Thymulin
A thymic peptide hormone studied in immune and endocrine signaling contexts.
Evidence score2/5
Early human evidence
- Evidence
- Mixed translational
- Status
- Published
Repair & matrix
GHK-Cu
A copper-binding tripeptide complex studied in matrix biology.
Evidence score3/5
Developing clinical evidence
- Evidence
- Mixed translational
- Status
- Published
Neuropeptides
Selank
A synthetic tuftsin-related heptapeptide.
Evidence score2/5
Early human evidence
- Evidence
- Early clinical
- Status
- Published
Featured studies
Grade ASystematic review and meta-analysis2025Indexed abstract extracted
Thymosin alpha 1 alleviates inflammation and prevents infection in patients with severe acute pancreatitis through immune regulation: a systematic review and meta-analysis
A systematic review and meta-analysis of five randomized studies in severe acute pancreatitis.
- Journal
- Frontiers in Immunology
- Evidence context
- High-level synthesis or controlled evidence
Grade AHuman randomized trial2025PubMed metadata verified
The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double-blinded, randomised, placebo-controlled, phase 3 trial.
Verified PubMed record for Thymosin Alpha 1: The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double-blinded, randomised, placebo-controlled, phase 3 trial.
- Journal
- BMJ (Clinical research ed.)
- Evidence context
- High-level synthesis or controlled evidence
Grade DReview2014PubMed metadata verified
The temporal dynamics of inflammation-related gene expression under tuftsin analog Selank action.
Verified PubMed record for Selank: The temporal dynamics of inflammation-related gene expression under tuftsin analog Selank action.
- Journal
- Molecular immunology
- Evidence context
- Metadata-only, mechanistic, or limited evidence
Comparisons
TA1 vs. ThymulinA structured research comparison between Thymosin Alpha 1 and Thymulin across compound identity, research category, evidence maturity, and interpretation boundaries.GHK-Cu vs. TA1A structured research comparison between GHK-Cu and Thymosin Alpha 1 across compound identity, research category, evidence maturity, and interpretation boundaries.GHK-Cu vs. BPC-157A structured research comparison between GHK-Cu and BPC-157 across compound identity, research category, evidence maturity, and interpretation boundaries.
Authority articles
Immune function
TA1 Research Overview
Thymosin alpha 1 has broader clinical literature than most Atlas peptides, but the evidence remains indication-specific.
Peptide research
GHK-Cu Research Overview
GHK-Cu has a deep matrix-biology footprint, but formulation and model boundaries determine what can be claimed.
Cognition
What Is Selank?
Selank’s strongest catalog value is as a mapped research cluster, not as a single simplified mechanism claim.